| Molecular Subtype IV breast Cancer | ||||
---|---|---|---|---|---|
 | CAF | CMF | p value* | ||
 | Patients (n = 22) | Patients (n = 17) |  | ||
Age at diagnosis | Â | Â | Â | Â | 0.464 |
< 50 yr | 15 | 68.2% | 14 | 82.4% | Â |
>= 50 yr | 7 | 31.8% | 3 | 17.6% | Â |
TNM Path T | Â | Â | Â | Â | 0.612 |
1 | 3 | 13.6% | 2 | 11.8% | Â |
2 | 19 | 86.4% | 13 | 76.5% | Â |
3 | 0 | 0.0% | 1 | 5.9% | Â |
4 | 0 | 0.0% | 1 | 5.9% | Â |
TNM Path N | Â | Â | Â | Â | 0.047 |
0 | 9 | 40.9% | 11 | 64.7% | Â |
1 | 12 | 54.5% | 3 | 17.6% | Â |
2 | 1 | 4.5% | 2 | 11.8% | Â |
3 | 0 | 0.0% | 1 | 5.9% | Â |
TNM Path M | Â | Â | Â | Â | 0.436 |
0 | 22 | 100.0% | 16 | 94.1% | Â |
1 | 0 | 0.0% | 1 | 5.9% | Â |
Positive Lymph Nodes | Â | Â | Â | 0.067 | |
0 | 9 | 40.9% | 11 | 64.7% | Â |
1-3 | 12 | 54.5% | 3 | 17.6% | Â |
4-9 | 1 | 4.5% | 2 | 11.8% | Â |
TNM Stage | Â | Â | Â | Â | 0.109 |
I | 0 | 0.0% | 2 | 11.8% | Â |
II | 21 | 95.5% | 12 | 70.6% | Â |
III | 1 | 4.5% | 2 | 11.8% | Â |
IV | 0 | 0.0% | 1 | 5.9% | Â |
Nuclear Grade | Â | Â | Â | Â | 0.495 |
1 | 1 | 4.5% | 0 | 0.0% | Â |
2 | 2 | 9.1% | 0 | 0.0% | Â |
3 | 19 | 86.4% | 17 | 100.0% | Â |
Post-op Radiation Rx | Â | Â | Â | 1.000 | |
No | 14 | 63.6% | 11 | 64.7% | Â |
Yes | 8 | 36.4% | 6 | 35.3% | Â |